000 01726 a2200505 4500
005 20250517163523.0
264 0 _c20190624
008 201906s 0 0 eng d
022 _a1557-7422
024 7 _a10.1089/hum.2017.062
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPotter, Rachael A
245 0 0 _aSystemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy.
_h[electronic resource]
260 _bHuman gene therapy
_c07 2018
300 _a749-762 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDNA, Complementary
_xadministration & dosage
650 0 4 _aDependovirus
_xgenetics
650 0 4 _aDisease Models, Animal
650 0 4 _aDysferlin
_xadministration & dosage
650 0 4 _aGene Expression Regulation
650 0 4 _aGenetic Therapy
650 0 4 _aGenetic Vectors
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMuscle, Skeletal
650 0 4 _aMuscular Dystrophies, Limb-Girdle
_xgenetics
650 0 4 _aMutation
700 1 _aGriffin, Danielle A
700 1 _aSondergaard, Patricia C
700 1 _aJohnson, Ryan W
700 1 _aPozsgai, Eric R
700 1 _aHeller, Kristin N
700 1 _aPeterson, Ellyn L
700 1 _aLehtimäki, Kimmo K
700 1 _aWindish, Hillarie P
700 1 _aMittal, Plavi J
700 1 _aAlbrecht, Douglas E
700 1 _aMendell, Jerry R
700 1 _aRodino-Klapac, Louise R
773 0 _tHuman gene therapy
_gvol. 29
_gno. 7
_gp. 749-762
856 4 0 _uhttps://doi.org/10.1089/hum.2017.062
_zAvailable from publisher's website
999 _c27367927
_d27367927